Related Experiment Video
Updated: Jun 28, 2025
03:22
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
421
Pulmonology: What You May Have Missed in 2023
Aram Karkar1, Sana Khan1, Rebecca O'Leary1
1McMaster University, Hamilton, Ontario, Canada (A.K., S.K., R.O., A.T.).
Annals of Internal Medicine
|April 15, 2024
Summary
Pulmonology advances in 2023 include new insights into asthma, COPD, and lung diseases. Key findings cover respiratory syncytial virus vaccination and novel COPD therapies.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Critical Care
Background:
- Significant advancements in pulmonology occurred in 2023.
- Publications reviewed cover asthma, COPD, interstitial lung disease, pleural disorders, and sleep-disordered breathing.
Purpose of the Study:
- To summarize key 2023 publications and practice changes in pulmonology.
- To highlight research on respiratory syncytial virus, COPD therapies, pleural disorders, and sleep-disordered breathing.
Main Methods:
- Review of recent publications and clinical recommendations.
- Analysis of studies on vaccination efficacy, various COPD treatments, and positive-pressure ventilation.
Main Results:
- Efficacy of respiratory syncytial virus vaccination was examined.
- Multiple COPD therapies (e.g., dupilumab, ensifentrine, pulmonary rehabilitation, lung volume reduction) were evaluated.
- Positive-pressure ventilation's effect on vascular events in sleep-disordered breathing patients was explored.
- Combination therapy for nonspecific interstitial pneumonia and inhaled corticosteroids for COPD were reviewed.
Conclusions:
- 2023 saw critical updates in pulmonology, impacting diagnosis and treatment across various respiratory conditions.
- Research highlights the importance of vaccination, targeted therapies for COPD, and managing sleep-disordered breathing.
More Related Videos
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
267
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
267
01:30Pneumonia III: Complications and Assessment
205
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
205
01:30Pulmonary Hypertension: Classification and Pathogenesis
173
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
173
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:17Other Pulmonary Disorders
836
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
836
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K